Bioventus BVS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Bioventus’s reported figures.
Based on trailing twelve months.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's return on equity?
- Bioventus (BVS) reported return on equity of 16.9% in Q1 2026.
- How has Bioventus's return on equity changed year-over-year?
- Bioventus's return on equity increased by 179.7% year-over-year, from -21.2% to 16.9%.
- What is the long-term trend for Bioventus's return on equity?
- Over 3 years (2022 to 2025), Bioventus's return on equity has grown at a -30.3% compound annual growth rate (CAGR), from -40.5% to 13.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.